CYDX (Cyduct Diagnostics) Beneish M-Score


What is Cyduct Diagnostics Beneish M-Score?

Cyduct Diagnostics does not have enough data to calculate Beneish M-Score.

Cyduct Diagnostics Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Cyduct Diagnostics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyduct Diagnostics Beneish M-Score Chart

Cyduct Diagnostics Annual Data
Trend
Beneish M-Score

Cyduct Diagnostics Quarterly Data
Beneish M-Score

CYDX vs SECI, QTXB, ASNB: Beneish M-Score Comparison

For the Medical Devices subindustry, Cyduct Diagnostics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyduct Diagnostics Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cyduct Diagnostics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Cyduct Diagnostics's Beneish M-Score falls into.


Cyduct Diagnostics Business Description

Address 1698 Post Road East, Suite 1A, Westport, CT, USA, 06880
Cyduct Diagnostics Inc is a clinical-stage diagnostic company. It focuses on creating and enhancing a portfolio of technologies and assets based on the early assessment and detection of Breast Cancer. Its technology platform of MammoView devices is a single-use, high-margin product that assesses, screens, detects, monitors, and facilitates the treatment of identifiable changes that distinguish variations in breast health. The company markets these products under its Solos Endoscopy brand, along with a line of branded surgical instruments, manufactured by third parties to its design specifications, mainly endoscopes and hand-held surgical instruments for the minimally invasive surgery market.